Skip to content

A study for safety evaluation of excess consumption of test food.

A study for safety evaluation of excess consumption of test food. - A study for safety evaluation of excess consumption of test food.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000040052
Enrollment
12
Registered
2020-04-04
Start date
2020-05-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Oral intake of the test foods (5 capsules in a day for 4 weeks)

Sponsors

Tashikani Plus Co., Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Healthy adults aged 20 to 80 years old. 2) Gender: No preference 3) Subjects without smoking habits 4) Subjects who do not have a habit of taking a meal containing a large amount of the tested food 5) Subjects who do not suffer from lifestyle diseases (high blood pressure, diabetes etc.), rheumatism, liver disorders, renal disorders, other chronic diseases 6) Subjects who have no history of treatment of malignant tumor, heart failure, myocardial infarction 7) Subjects who have no history of allergy to test foods / medicines 8) Subjects who do not take medication for Outpatient treatment 9) Subjects who do not regularly use health foods 10) Subjects giving written informed consent

Exclusion criteria

Exclusion criteria: 1) Females who are pregnant or lactating, and females who could become pregnant or lactating during test period 2) Subjects who are participating the other clinical tests. Subjects who participated within 3-month prior to the current study 3) Subjects who do not comply with instructions from the doctor or medical staff 4) Others who have been determined ineligible by investigator

Design outcomes

Primary

MeasureTime frame
conduct examinations and tests at 0 week and at 2 and 4 weeks. Hematology test Blood biochemistry test Urinalysis Blood pressure/pulsation Body weight Doctor's questions Adverse event

Countries

Japan

Contacts

Public ContactTaisuke Fukaya

Tashikani Plus Co., Ltd CEO

fukaya@tashikani.jp06-6352-6622

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026